ALX Oncology Holdings Inc. (ALXO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.28 |
| Open | 9.09 |
| Bid | 8.99 x 200 |
| Ask | 9.06 x 200 |
| Day's range | 8.85 - 9.40 |
| 52-week range | 3.94 - 17.83 |
| Volume | |
| Avg. volume | 678,512 |
| Market cap | 469.422M |
| Beta (5Y monthly) | 1.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Replimune (REPL) Gains on Positive Data From Melanoma Study
Replimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall response rate of 33.6% in patients with anti-PD1 failed melanoma. Shares gain.
- Zacks
Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%
Halozyme (HALO) gains 13% as it raises its full-year 2024 financial guidance and updates its five-year financial outlook based on the new ENHANZE patent grant in Europe.
- Zacks
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Vir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and elebsiran for the treatment of people living with chronic hepatitis delta.
© 2024 Yahoo. All rights reserved.